Spinal cord injuries induce changes in CB1 cannabinoid receptor and C-C chemokine expression in brain areas underlying circuitry of chronic pain conditions

Journal of Neurotrauma

Volumn 28, Issue 4, 2011, Pages 619-634

  Knerlich Lukoschus, Friederike ^a,b   Noack, Malte ^a   Von Der Ropp Brenner, Beata ^a   Lucius, Ralph ^b   Mehdorn, Hubertus Maximilian ^a   Held Feindt, Janka ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

cannabinoid receptor 1; central pain; chemokines; spinal cord injury; transient receptor potential vanilloid receptor 1

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR TYPE 1; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CINGULATE; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DOWN REGULATION; HIPPOCAMPUS; IMMUNOREACTIVITY; NEUROPATHIC PAIN; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; THALAMUS;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHEMOKINES, CC; DOWN-REGULATION; IMMUNOHISTOCHEMISTRY; MALE; MOTOR ACTIVITY; NEURONS; PAIN; PAIN MEASUREMENT; RATS; RATS, LONG-EVANS; RECEPTOR, CANNABINOID, CB1; SPINAL CORD INJURIES; TRPV CATION CHANNELS;

EID: 79953808359     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2010.1652     Document Type: Article

References (60)

1. Ahmed, M.M., Rajpal, S., Sweeney, C., Gerovac, T.A., Allcock, B., McChesney, S., Patel, A.U., Tilghman, J.I., Miranpuri, G.S., and Resnick, D.K. (2010). Cannabinoid subtype-2 receptors modu-late the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain. Spine 10,1049-1054.
2. Adler, M.W., Geller, E.B., Chen, X., and Rogers, T.J. (2005). Viewing chemokines as a third major system of communica-tion in the brain. AAPS J. 7, E865-E870.
3. Baastrup, C., and Finnerup, N.B. (2008). Pharmacological man-agement of neuropathic pain following spinal cord injury. CNS Drugs 22, 455-475. (Pubitemid 351693689)
4. Banisadr, G., Gosselin, RD., Mechighel, P., Kitabgi, P., Rostene, W., and Parsadaniantz, S.M. (2005a). Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J. Comp. Neurol. 489, 275-292. (Pubitemid 41026230)
5. Banisadr, G., Gosselin, RD., Mechighel, P., Rostene, W., Kitabgi, P., and Melik Parsadaniantz, S. (2005b). Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J. Comp. Neurol. 492, 178-192. (Pubitemid 41443720)
6. Benamar, K., Geller, E.B., and Adler, M.W. (2008). First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain. J. Pharmacol. Exp. Ther. 325, 641-645. (Pubitemid 351574816)
7. Chen, X., Geller, E.B., Rogers, T.J., and Adler, M.W. (2007). Ra-pid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine recep-tors in rats. Drug Alcohol Depend. 88, 36-41. (Pubitemid 46400302)
8. Corasaniti, M.T., Amantea, D., Russo, R., and Bagetta, G (2006). The crucial role of neuronal plasticity in pain and cell death Cell Death Differ. 13, 534-536.
9. Cristino, L., de Petrocellis, L., Pryce, G., Baker, D., Guglielmotti, V., and Di Marzo, V. (2006). Immunohistochemical localiza-tion of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neu-roscience 139, 1405-1415.
10. Davis, J.B., Gray, J., Gunthorpe, M.J., Hatcher, J.P., Davey, P.T., Overend, P., Harries, M.H., Latcham, J., Clapham, C., Atkin-son, K., Hughes, S.A., Rance, K., Grau, E., Harper, A.J., Pugh, P.L., Rogers, D.C., Bingham, S., Randall, A., and Sheardown, S.A. (2000). Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405, 183-187. (Pubitemid 30313536)
11. De Wied, D., and Croiset, G (1991). Stress modulation of learning and memory processes. Methods Achiev. Exp. Pathol. 15, 167-199.
12. Di Marzo, V., Melck, D., Bisogno, T., and De Petrocellis, L. (1998). Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21, 521-528. (Pubitemid 28555694)
13. Egertova, M., and Elphick, M.R. (2000). Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J. Comp. Neurol. 422, 159-171. (Pubitemid 30390161)
14. Egertova, M., Cravatt, B.F., and Elphick, M.R (2003). Com-parative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regu-lation of endocannabinoid signaling. Neuroscience 119, 481-496. (Pubitemid 36588826)
15. Farquhar-Smith, W.P., Egertova, M., Bradbury, E.J., McMahon, S.B., Rice, AS., and Elphick, M.R (2000). Cannabinoid CB(1) receptor expression in rat spinal cord. Mol. Cell Neurosci. 15, 510-521. (Pubitemid 30436925)
16. Fernandez-Ruiz, J., Berrendero, F., Hernandez, M.L., and Ra-mos, J.A. (2000). The endogenous cannabinoid system and brain development. Trends Neurosci. 23, 14-20. (Pubitemid 30100308)
17. Finnerup, N.B., and Jensen, T.S. (2004). Spinal cord injury pain\mechanisms and treatment. Eur. J. Neurol. 11, 73-82. (Pubitemid 38230781)
18. Gong, J.P., Onaivi, E.S., Ishiguro, H., Liu, Q.R., Tagliaferro, P.A., Brusco, A., and Uhl, GR (2006). Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 1071, 10-23. (Pubitemid 43255471)
19. Grimsey, N.L., Goodfellow, CE., Scotter, E.L., Dowie, M.J., Glass, M., and Graham, E.S. (2008). Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal! J. Neurosci. Methods 171, 78-86.
20. Hubscher, C.H., and Johnson, R.D. (2006). Chronic spinal cord injury induced changes in the responses of thalamic neurons. Exp. Neurol. 197, 177-188. (Pubitemid 41819087)
21. Hulsebosch, C.E. (2005). From discovery to clinical trials: treat-ment strategies for central neuropathic pain after spinal cord injury. Curr. Pharm. Des. 11, 1411-1420. (Pubitemid 40590189)
22. Hulsebosch, C.E., Hains, B.C., Crown, E.D., and Carlton, S.M. (2009). Mechanisms of chronic central neuropathic pain after spinal cord injury. Brain Res. Rev. 60, 202-213.
23. Hulsebosch, C.E. (2002). Recent advances in pathophysiology and treatment of spinal cord injury. Adv. Physiol. Educ 26, 238-255.
24. Jalalvand, E., Javan, M., Haeri-Rohani, A., and Ahmadiani, A. (2008). Stress-and non-stress-mediated mechanisms are in-volved in pain-induced apoptosis in hippocampus and dorsal lumbar spinal cord in rats. Neuroscience 157, 446-452.
25. Jensen, M.P., Kuehn, C.M., Amtmann, D., and Cardenas, D.D. (2007). Symptom burden in persons with spinal cord injury. Arch. Phys. Med. Rehabil. 88, 638-645. (Pubitemid 46627535)
26. Katona, I., Rancz, EA., Acsady, L., Ledent, C., Mackie, K., Hajos, N., and Freund, T.F. (2001). Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 21, 9506-9518. (Pubitemid 33096895)
27. Katona, I., Sperlagh, B., Sik, A., Kafalvi, A., Vizi, E.S., Mackie, K., and Freund, T.F. (1999). Presynaptically located CB1 canna-binoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19, 4544-4558. (Pubitemid 29241104)
28. Kauer, J.A., and Gibson, H. E. (2008). Hot flash: TRPV channels in the brain. TINS 32, 215-295.
29. Kim, S.R., Lee, D.Y., Chung, E.S., Oh, U.T., Kim, S.U., and Jin, B.K. (2005). Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. J. Neurosci. 25, 662-671.
30. Knerlich-Lukoschus, F., Juraschek, M., Blomer, U., Lucius, R., Mehdorn, H.M., and Held-Feindt, J. (2008). Force-dependent development of neuropathic central pain and time-related CCL2/CCR2 expression after graded spinal cord contusion injuries of the rat. J. Neurotrauma 25, 427-448. (Pubitemid 351685487)
31. Knerlich-Lukoschus, F., von der Ropp-Brenner, B., Lucius, R., Mehdorn, H.M., and Held-Feindt, J. (2010b). Chemokine ex-pression in the white matter spinal cord precursor niche after force-defined spinal cord contusion injuries in adult rats. Glia 58, 916-931.
32. Knerlich-Lukoschus, F., von der Ropp-Brenner, B., Mehdorn, H.M., and Held-Feindt, J. (2010a). Expression patterns of chemokines and cannabinoid CB1 receptor in a rat spinal cord injury model of chronic post traumatic neuropathic pain. J. Neurotrauma 27, A-1-A97 (28th Annual National Neuro-trauma Symposium June 14-17, 2010, Las Vegas, Nevada).
33. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Be-slot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., Vassart, G., Fratta, W., and Parmentier, M. (1999). Un-responsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401-404.
34. Maione, S., Bisogno, T., de Novellis, V., Palazzo, E., Cristino, L., Valenti, M., Petrosino, S., Guglielmotti, V., Rossi, F., and Di Marzo, V. (2006). Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive path-ways via both cannabinoid receptor type 1 and transient re-ceptor potential vanilloid type-1 receptors. J. Pharmacol. Exp. Ther. 316, 969-982. (Pubitemid 43345268)
35. Mezey, E., Toth, Z.E., Cortright, D.N., Arzubi, M.K., Krause, J.E., Elde, R, Guo, A., Blumberg, P.M., and Szallasi, A. (2000). Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl. Acad. Sci. USA 97, 3655-3660. (Pubitemid 30183358)
36. Miller, R.J., Rostene, W., Apartis, E., Banisadr, G., Biber, K., Milligan, E.D., White, F.A., and Zhang, J. (2008). Chemokine action in the nervous system. J. Neurosci. 28, 11792-11795.
37. Munro, S., Thomas, K.L., and Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65. (Pubitemid 23305569)
38. Neugebauer, V., Li, W., Bird, G.C., and Han, J.S. (2004). The amygdala and persistent pain. Neuroscientist 10, 221-234. (Pubitemid 38678530)
39. Onaivi, E.S., Green, M.R, and Martin, B.R (1990). Pharmacolo-gical characterization of cannabinoids in the elevated plus maze. J. Pharmacol. Exp. Ther. 253, 1002-1009. (Pubitemid 20209356)
40. Paxinos, G., and Watson, C. (2007). The Rat Brain in Stereotaxic Coordinates. Academic Press: London, U.K
41. Perńa-Andrade, A.J., Kato, A., Witschi, R., Nyilas, R., Katona, I., Freund, T.F., Watanabe, M., Filitz, J., Koppert, W., Schüttler, J., Ji, G., Neugebauer, V., Marsicano, G., Lutz, B., Vanegas, H., and Zeilhofer, H.U. (2009). Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensi-tization. Science 325, 760-764.
42. Pertwee, RG. (2001). Cannabinoid receptors and pain. Prog. Neurobiol. 63, 569-611. (Pubitemid 32115433)
43. Petrosino, S., Palazzo, E., de Novellis, V., Bisogno, T., Rossi, F., Maione, S., and Di Marzo, V. (2007). Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology 52, 415-422. (Pubitemid 46127787)
44. Pettit, D.A., Harrison, M.P., Olson, J.M., Spencer, RF., and Cabral, G.A. (1998). Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J. Neurosci. Res. 51, 391-402. (Pubitemid 28078470)
45. Roberts, J.C., Davis, J.B., and Benham, C.D. (2004). [3H]Re-siniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res. 995, 176-183. (Pubitemid 37522018)
46. Ross, R.A. (2003). Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 140, 790-801. (Pubitemid 37464060)
47. Rostene, W., Kitabgi, P., and Parsadaniantz, S.M. (2007). Che-mokines: a new class of neuromodulator? Nat. Rev. Neurosci. 8, 895-903.
48. Sagar, D.R, Smith, P.A., Millns, P.J., Smart, D., Kendall, D.A., and Chapman, V. (2004). TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachido-noyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat. Eur. J. Neurosci. 20, 175-184. (Pubitemid 38932138)
49. Scheff, S.W., Rabchevsky, A.G., Fugaccia, I., Main, J.A., and Lumpp, J.E., Jr. (2003). Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 20, 179-193. (Pubitemid 36292827)
50. Szabo, I., Chen, X.H., Xin, L., Adler, M.W., Howard, O.M., Oppenheim, J.J., and Rogers, T.J. (2002). Heterologous desen-sitization of opioid receptors by chemokines inhibits chemo-taxis and enhances the perception of pain. Proc Natl. Acad. Sci. USA 99, 10276-10281.
51. Tsou, K., Brown, S., Sanudo-Pena, M.C., Mackie, K., and Walker, J.M. (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83, 393-411. (Pubitemid 28062631)
52. Vogt, B.A. (2005). Pain and emotion interactions in subregions of the cingulate gyrus. Nat. Rev. Neurosci. 6, 533-544. (Pubitemid 40942820)
53. Watanabe, Y., Gould, E., and McEwen, B.S. (1992). Stress in-duces atrophy of apical dendrites of hippocampal CA3 pyra-midal neurons. Brain Res. 588, 341-345.
54. Wilson, R.I., and Nicoll, R.A. (2002). Endocannabinoid signaling in the brain. Science 296, 678-682.
55. Wolf, S.A., Bick-Sander, A., Fabel, K., Leal-Galicia, P., Tauber, S., Ramirez-Rodriguez, G., Muller, A., Melnik, A., Waltinger, T.P., Ullrich, O., and Kempermann, G (2010). Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Cell Commun. Signal 8, 12.
56. Zhang, H., Xie, W., and Xie, Y. (2005a). Spinal cord injury trig-gers sensitization of wide dynamic range dorsal horn neurons in segments rostral to the injury. Brain Res. 1055, 103-110. (Pubitemid 41224233)
57. Zhang, N., Inan, S., Cowan, A., Sun, R, Wang, J.M., Rogers, T.J., Caterina, M., and Oppenheim, J.J. (2005b). A proinflammatory chemokine, CCL3, sensitizes the heat-and capsaicin-gated ion channel TRPV1. Proc Natl. Acad. Sci. USA 102, 4536-4541. (Pubitemid 40397147)
58. Zhang, N., Rogers, T.J., Caterina, M., and Oppenheim, J.J. (2004). Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J. Immunol. 173, 594-599. (Pubitemid 38797388)
59. Zhao, P., Waxman, S.G, and Hains, B.C (2007). Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine chemokine ligand 21. J. Neurosci. 27, 8893-8902. (Pubitemid 47292772)
60. Zhu, CZ., Mikusa, J.P., Fan, Y., Hollingsworth, P.R, Pai, M., Chandran, P., Daza, A.V., Yao, B.B., Dart, M.J., Meyer, M.D., Decker, M.W., Hsieh, G.C., and Honore, P. (2009). Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain. Br. J. Pharmacol. 157, 645-655.